| Acute Leukemia |
1 |
1 |
| Chemotherapy |
0 |
0.98 |
| Remission |
0 |
0.56 |
| Stem Cell Research and Therapy |
0 |
0.42 |
| Transplantation |
0 |
0.99 |
| Cell Transplantation |
0 |
0.32 |
| Quality of Life |
0 |
0.27 |
| Transplant Evaluation |
0 |
0.26 |
| Residual Disease |
0 |
0.17 |
| Acute Myeloblastic Leukemia |
0 |
0.08 |
| Fungal Infection |
0 |
0.07 |
| Healthcare and Medical Technology |
0 |
0.07 |
| Antifungal |
0 |
0.06 |
| Antiviral Agents |
0 |
0.06 |
| Blood |
0 |
0.06 |
| Cancer |
0 |
0.06 |
| Clinical Research |
0 |
0.06 |
| Disease Surveillance |
0 |
0.06 |
| Flow Cytometry |
0 |
0.06 |
| Grant |
0 |
0.06 |
| Leukemia |
0 |
0.06 |
| Prophylaxis |
0 |
0.06 |
| Vermont |
0 |
0.06 |